Ticker Details
Atai Life Sciences N.V. ATA Inc is a computer-based testing service provider. The company offers testing systems such as test development, test delivery, and data management. It also provides test-based training, education programs, and test preparation courses to individuals.
IPO Date:	June 18, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.41B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 3.75%
Avg Daily Range (30 D):	$0.11 | 3.01%
Avg Daily Range (90 D):	$0.15 | 3.40%

Institutional Daily Volume
Avg Daily Volume:	1.7M
Avg Daily Volume (30 D):	3.62M
Avg Daily Volume (90 D):	4.28M

Trade Size
Avg Trade Size (Sh.):	221
Avg Trade Size (Sh.) (30 D):	197
Avg Trade Size (Sh.) (90 D):	207

Institutional Trades
Total Institutional Trades:	237
Avg Institutional Trade:	$1.32M
Avg Institutional Trade (30 D):	$.84M
Avg Institutional Trade (90 D):	$1.26M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.33M
Avg Closing Trade (30 D):	$.89M
Avg Closing Trade (90 D):	$1.25M
Avg Closing Volume:	350.52K

News

Jan 16, 2026 @ 12:00 PM AtaiBeckley Participates in the 64th Annual ACNP M... Source: Ataibeckley Inc.

Jan 8, 2026 @ 12:00 PM AtaiBeckley Provides Update and Outlook for 2026 A... Source: Ataibeckley Inc

Oct 17, 2025 @ 12:06 PM Why Atai Life Sciences Stock Was So Lively This We... Source: Eric Volkman

Oct 17, 2025 @ 2:31 AM atai Life Sciences Announces Pricing of Public Off... Source: Atai Life Sciences

Sep 18, 2025 @ 12:00 PM atai Life Sciences Awarded Grant from the National... Source: Atai Life Sciences

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.81	$-.28	$-.14
Diluted EPS	$-.81	$-.28	$-.14
Revenue	$3.02M	$.75M	$.72M
Gross Profit
Net Income / Loss	$-154.3M	$-61.1M	$-27.75M
Operating Income / Loss	$-104.34M	$-28.44M	$-25.27M
Cost of Revenue
Net Cash Flow	$-14.45M	$-31.07M	$3.45M
PE Ratio